Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 309.42 billion. The enterprise value is 303.79 billion.

Market Cap	309.42B
Enterprise Value	303.79B

Important Dates

The last earnings date was Sunday, July 27, 2025.

Earnings Date	Jul 27, 2025
Ex-Dividend Date	Nov 6, 2024

Share Statistics

Ajanta Pharma has 124.89 million shares outstanding. The number of shares has decreased by -0.82% in one year.

Current Share Class	124.89M
Shares Outstanding	124.89M
Shares Change (YoY)	-0.82%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	42.34%
Owned by Institutions (%)	21.46%
Float	41.84M

Valuation Ratios

The trailing PE ratio is 33.29 and the forward PE ratio is 28.89. Ajanta Pharma's PEG ratio is 2.63.

PE Ratio	33.29
Forward PE	28.89
PS Ratio	6.44
PB Ratio	8.16
P/TBV Ratio	8.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.63

Enterprise Valuation

EV / Earnings	32.67
EV / Sales	6.32
EV / EBITDA	23.29
EV / EBIT	26.03
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	n/a
Interest Coverage	46.21

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	19.60%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	4.99M
Profits Per Employee	965,891
Employee Count	9,628
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Ajanta Pharma has paid 2.68 billion in taxes.

Income Tax	2.68B
Effective Tax Rate	22.38%

Stock Price Statistics

The stock price has decreased by -19.57% in the last 52 weeks. The beta is 0.17, so Ajanta Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-19.57%
50-Day Moving Average	2,653.00
200-Day Moving Average	2,697.79
Relative Strength Index (RSI)	31.73
Average Volume (20 Days)	92,708

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 48.06 billion and earned 9.30 billion in profits. Earnings per share was 74.42.

Revenue	48.06B
Gross Profit	36.55B
Operating Income	11.67B
Pretax Income	11.98B
Net Income	9.30B
EBITDA	12.92B
EBIT	11.67B
Earnings Per Share (EPS)	74.42

Balance Sheet

The company has 6.14 billion in cash and 509.20 million in debt, giving a net cash position of 5.63 billion or 45.07 per share.

Cash & Cash Equivalents	6.14B
Total Debt	509.20M
Net Cash	5.63B
Net Cash Per Share	45.07
Equity (Book Value)	37.90B
Book Value Per Share	301.59
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 76.05%, with operating and profit margins of 24.29% and 19.35%.

Gross Margin	76.05%
Operating Margin	24.29%
Pretax Margin	24.93%
Profit Margin	19.35%
EBITDA Margin	26.89%
EBIT Margin	24.29%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 1.13%.

Dividend Per Share	28.00
Dividend Yield	1.13%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	0.82%
Shareholder Yield	1.93%
Earnings Yield	3.01%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2